← THE EVIDENCE INDEXThe Study Library.
8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Showing studies that examined mushrooms. Clear
People assigned to a diet, food or program and measured.
3 studies
2016 / Double-blind, placebo-controlled human clinical trial
A double-blind, placebo-controlled clinical trial evaluated the immune-modulating effects of Pleurotus cornucopiae (Oyster mushroom, Tamogitake) extract ingested for 8 weeks. Intake of the extract significantly elevated serum IFN-γ (P = 0.013) and elevated IL-12, whereas serum levels of IL-10, IL-13, and other cytokines showed minimal changes. Natural killer cell activity tended to increase, but the change was not statistically significant.
Tanaka A, Nishimura M, Sato Y, et al. J Tradit Complement Med, 2016. PMID 27774430
2015 / Randomized controlled trial
Fifty-two healthy adults consumed 5 g or 10 g of dried shiitake mushrooms daily for 4 weeks in a parallel-group trial. Mushroom intake increased ex vivo proliferation of γδ-T cells by 60% and natural killer T cells twofold (both p < 0.0001), along with greater activation receptor expression. Salivary secretory immunoglobulin A increased and serum C-reactive protein decreased, accompanied by distinct shifts in cytokine secretion profiles.
Dai X, Stanilka JM, Rowe CA, et al. J Am Coll Nutr, 2015. PMID 25866155
2012 / Randomized controlled trial
In a randomized trial, 24 healthy adults consumed their normal diet alone or with 100 g daily of blanched white button mushrooms for one week. The mushroom group showed a significant increase in mean salivary immunoglobulin A secretion rate of 53% at week one and 56% at week two relative to week zero (P < 0.0005), returning to baseline by week three. No significant changes occurred in the control group.
Jeong SC, Koyyalamudi SR, Pang G Nutrition, 2012. PMID 22113068